Effect of dexamethasone on adipocyte differentiation markers and tumour necrosis factor-α expression in human PAZ6 cells

Diabetologia

Volumn 44, Issue 3, 2001, Pages 377-386

  Zilberfarb, V ^a   Siquier, K ^a   Strosberg, A D ^a   Issad, T ^a  

^a INSTITUT COCHIN   (France)

Author keywords

Adipocyte differentiation; Dexamethasone; Gene expression; Glucocorticoids; Insulin resistance; Obesity; TNF

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; DEXAMETHASONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; DRUG EFFECT; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

ADIPOCYTES; BIOLOGICAL MARKERS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; DEXAMETHASONE; GENE EXPRESSION REGULATION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; NEOPLASM PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035076381     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051630     Document Type: Article

References (46)

1. Adipose expression of tumour necrosis factor-alpha: Direct role in obesity-linked insulin resistance
2. Tumour necrosis factor alpha: A key component of the obesity-diabetes link
3. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumour necrosis factor-alpha
4. Tumour necrosis factor alpha inhibits signaling from the insulin receptor
5. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance
6. Tumour necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction
7. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumour necrosis factor-alpha
8. The expression of tumour necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relation to lipoprotein lipase
9. Increased adipose tissue expression of tumour necrosis factor-alpha in human obesity and insulin resistance
10. Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumour necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis
11. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture
12. Through thick and thin: Wasting, obesity, and TNF alpha
13. The expression of TNF alpha by human muscle. Relation to insulin resistance
14. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM
15. The phosphodiesterase inhibitor IBMX suppresses TNF-alpha expression in human adipocyte precursor cells: A possible explanation for its adipogenic effect
16. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro
17. Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis
18. Human immortalized brown adipocytes express functional beta3-adrenoceptor coupled to lipolysis
19. Desensitization of the beta-adrenergic response in human brown adipocytes
20. Effect of thiazolidinediones on expression of UCP2 and adipocyte markers in human PAZ6 adipocytes
21. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O
22. Id helix-loop-helix proteins in cell growth and differentiation
23. Tumour necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: Implication of the p80 tumour necrosis factor receptor
24. Understanding adipocyte differentiation
25. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins
26. The antiglucocorticoid RU38486 is a potent accelerator of adipose conversion of 3T3-F442A cells
27. Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells
28. The stroma-vascular fraction of rat inguinal and epididymal adipose tissue and the adipoconversion of fat cell precursors in primary culture
29. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells
30. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium
31. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells
32. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids
33. The role of C/EBP genes in adipocyte differentiation
34. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
35. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha
36. Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation
37. Tumour necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells
38. Id3 prevents differentiation of preadipose cells
39. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes
40. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism
41. Enhancement of adipocyte differentiation by an insulin-sensitizing agent
42. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells
43. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
44. Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells
45. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle
46. Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes